Data as of Sep 02
| -0.09 / -0.71%|
The 23 analysts offering 12-month price forecasts for Boston Scientific Corp have a median target of 14.50, with a high estimate of 18.00 and a low estimate of 11.00. The median estimate represents a +15.17% increase from the last price of 12.59.
The current consensus among 25 polled investment analysts is to Buy stock in Boston Scientific Corp. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.